| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.84B | +12.2% |
| R&D Expense | $309.6M | +22.7% |
| SG&A Expense | $3.58B | +20.8% |
| Operating Income | $3.50B | +20.9% |
| Interest Expense | $238.4M | +1.7% |
| Pre-tax Income | $3.24B | +26.3% |
| Income Tax | $627.6M | +25.9% |
| Net Income | $2.57B | +26.9% |
| EPS (Basic) | $11.35 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.59B | +45.2% |
| Accounts Receivable | $3.09B | +4.5% |
| Inventory | $1.97B | -8.4% |
| Current Assets | $7.34B | +6.8% |
| Total Assets | $20.15B | +3.9% |
| Current Liabilities | $6.07B | +0.3% |
| Long-term Debt | $4.77B | -0.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.15B | +31.6% |
| Capital Expenditures | $370.6M | +23.2% |
| Investing Cash Flow | -$562.9M | +52.0% |
| Financing Cash Flow | -$2.02B | -49.6% |
| Free Cash Flow | $2.77B | +32.8% |
| +28.2% |
| EPS (Diluted) | $11.24 | +28.2% |
| Total Liabilities |
| $12.66B |
| +2.3% |
| Stockholders' Equity | $7.46B | +6.6% |